| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 87.177 | - | - | 280.161 | 321.611 | 369.535 | 275.084 | 351.250 | 342.490 |
| Total Income - EUR | - | 87.177 | - | - | 280.161 | 342.771 | 369.535 | 275.084 | 351.250 | 372.645 |
| Total Expenses - EUR | - | 2.838 | - | - | 75.210 | 66.127 | 65.943 | 68.877 | 51.493 | 59.569 |
| Gross Profit/Loss - EUR | - | 84.339 | - | - | 204.951 | 276.644 | 303.592 | 206.207 | 299.757 | 313.075 |
| Net Profit/Loss - EUR | - | 83.543 | - | - | 202.149 | 273.218 | 299.896 | 203.456 | 296.315 | 302.119 |
| Employees | - | 0 | - | - | 1 | 0 | 1 | 0 | 1 | 1 |
Check the financial reports for the company - Topmed Fiv Project Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | - | - | 36.455 | 69.203 | 99.854 | 70.493 | 40.697 | 94.653 |
| Current Assets | - | 83.765 | - | - | 188.512 | 239.158 | 431.462 | 237.935 | 335.656 | 291.240 |
| Inventories | - | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 14.166 | - | - | 99.188 | 182.754 | 314.973 | 194.712 | 279.426 | 249.870 |
| Cash | - | 69.599 | - | - | 89.324 | 56.405 | 116.488 | 43.224 | 56.229 | 41.370 |
| Shareholders Funds | - | 267 | - | - | 202.402 | 273.466 | 300.139 | 203.699 | 296.558 | 302.361 |
| Social Capital | - | 223 | - | - | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | 83.498 | - | - | 22.565 | 35.182 | 231.353 | 104.944 | 80.149 | 86.437 |
| Income in Advance | - | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Topmed Fiv Project Srl